China NMPA Product Recall - Vital Nerve Monitoring System

On September 2, 2024, the National Medical Products Administration (NMPA) issued an alert regarding a Class I voluntary recall initiated by Medtronic Xomed, Inc. This significant action targets the company's Vital Nerve Monitoring System, identifiable by National Medical Device Registration Certificate No. 20233070120. The recall was reported by Medtronic (Shanghai) Management Co., Ltd., acting on behalf of the manufacturer. The primary concern driving this recall involves critical performance issues, specifically the occurrence of false negative reactions in certain products within the affected batches. A Class I recall, under the NMPA's regulatory framework, signifies the most severe level of recall. This classification is reserved for situations where there is a high probability that the use of, or exposure to, the recalled medical device could lead to serious adverse health consequences or potentially even death. Medtronic Xomed, Inc. is proactively undertaking this voluntary recall to mitigate potential risks to patients and healthcare professionals. The company is required to remove the affected neuromonitoring devices from distribution and use. Detailed information concerning the precise models, specifications, and batch numbers of the products involved in this recall are available in the attached "Medical Device Recall Event Report Form," which provides comprehensive guidance for affected parties. This regulatory action emphasizes the importance of product reliability and patient safety within the medical device industry.